Adrian Kilcoyne
2021 - KaloBios Pharmaceuticals
In 2021, Adrian Kilcoyne earned a total compensation of $2.4M as Chief Medical Officer at KaloBios Pharmaceuticals.
Compensation breakdown
| Non-Equity Incentive Plan | $92,421 |
|---|---|
| Option Awards | $2,006,103 |
| Salary | $296,212 |
| Total | $2,394,736 |
Kilcoyne received $2M in option awards, accounting for 84% of the total pay in 2021.
Kilcoyne also received $92.4K in non-equity incentive plan and $296.2K in salary.
Rankings
In 2021, Adrian Kilcoyne's compensation ranked 5,326th out of 12,415 executives tracked by ExecPay. In other words, Kilcoyne earned more than 57.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,326 out of 12,415 | 57th |
Division Manufacturing | 2,238 out of 5,505 | 59th |
Major group Chemicals And Allied Products | 976 out of 2,375 | 59th |
Industry group Drugs | 869 out of 2,096 | 59th |
Industry Pharmaceutical Preparations | 624 out of 1,546 | 60th |
Source: SEC filing on April 12, 2022.
Kilcoyne's colleagues
We found two more compensation records of executives who worked with Adrian Kilcoyne at KaloBios Pharmaceuticals in 2021.